Content area
Full Text
[Image omitted] - (http://www.fiercepharma.com/special-reports/pharmas-top-10-ma-deals-2014s-first-half) Mergers and acquisitions have been non-stop this year, with lots of deals done, and some doozies that were unable to cross the finish line. Here we look at what's happened in the first half of the year; we will round out the entire year's activity in another report early next year.
The top 10 deals in the first half of 2014 totaled nearly $90 billion in value, with Actavis' ($ACT) $25 billion deal for Forest topping the list. According to EvaluatePharma's estimates , the deals worth about $50 billion surfaced in just the second quarter, making it the biggest quarter since...